At a glance
Promopharm makes and sells medicines in Morocco. At the end of 2025 it commissioned a new plant for injectable medicines.
History
Promopharm was founded in 1947. It produces, imports and markets medicines, parapharmacy, dermatology and cosmetic products. It has been listed on the Casablanca Stock Exchange since 2007.
Latest published results
In the first half of 2026, revenue rose 9% to MAD 507 million, thanks to new products. Net income fell 74% to MAD 6.8 million, mainly because of depreciation and financing costs at the new injectables plant.
What to watch
The ramp-up of the injectables plant, which needs to absorb its costs.
Key dates
- 1947
Company founded.
- 2007
First listing on the Casablanca Stock Exchange.
- 2025
Injectable medicines plant comes on stream at the end of the year.
- 2026
Profit warning in September, then half-year profit down 74%.
Sources: Boursenews, Promopharm : résultats du premier semestre 2026, October 1, 2026; African Markets, fiche société Promopharm, October 29, 2026.
Profile updated on October 29, 2026.